Align Technology, Inc.
$194.19
▼
-0.52%
2026-04-22 10:12:13
www.aligntech.com
NMS: ALGN
Explore Align Technology, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$14 B
Current Price
$194.19
52W High / Low
$208.31 / $122
Stock P/E
34.46
Book Value
$56.74
Dividend Yield
—
ROCE
13.57%
ROE
10.39%
Face Value
—
EPS
$5.65
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
20,290
Beta
1.81
Debt / Equity
2.83
Current Ratio
1.36
Quick Ratio
1.24
Forward P/E
14.11
Price / Sales
3.07
Enterprise Value
$11.36 B
EV / EBITDA
13.35
EV / Revenue
2.82
Rating
Buy
Target Price
$201.69
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
| 2. | Stevanato Group S.p.A. | $15.86 | 26.32 | $4.33 B | 0.39% | 9.9% | 9.67% | $28 / $12.89 | $6.28 |
| 3. | Ekso Bionics Holdings, Inc. | $11.38 | — | $40.55 M | — | -116.13% | -1.08% | $13.5 / $2.73 | $2.54 |
| 4. | Regentis Biomaterials Ltd. | $2.96 | — | — | — | -181.68% | 75.07% | $8.35 / $2.8 | $0.92 |
| 5. | Sharps Technology, Inc. | $1.84 | — | $73.85 M | — | -452.36% | -2.03% | $18.23 / $1.42 | $15.68 |
| 6. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 7. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.05 B | 995.69 M | 1.01 B | 979.26 M | 995.22 M | — |
| Operating Profit | 158.88 M | 128.12 M | 163.03 M | 135.28 M | 177.09 M | — |
| Net Profit | 135.76 M | 56.75 M | 124.61 M | 93.23 M | 103.81 M | — |
| EPS in Rs | 1.9 | 0.79 | 1.74 | 1.3 | 1.45 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.03 B | 4 B | 3.86 B | 3.73 B |
| Operating Profit | 585.31 M | 671.76 M | 656.65 M | 654.05 M |
| Net Profit | 410.35 M | 421.36 M | 445.05 M | 361.57 M |
| EPS in Rs | 5.73 | 5.88 | 6.21 | 5.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.23 B | 6.21 B | 6.08 B | 5.95 B |
| Total Liabilities | 2.18 B | 2.36 B | 2.45 B | 2.35 B |
| Equity | 4.05 B | 3.85 B | 3.63 B | 3.6 B |
| Current Assets | 2.62 B | 2.49 B | 2.45 B | 2.42 B |
| Current Liabilities | 1.92 B | 2.04 B | 2.07 B | 1.93 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 593.22 M | 738.23 M | 785.78 M | 568.73 M |
| Investing CF | -112.44 M | -254.91 M | -195.94 M | -213.32 M |
| Financing CF | -464.58 M | -355.72 M | -598.34 M | -501.69 M |
| Free CF | 490.78 M | 622.65 M | 608.06 M | 276.83 M |
| Capex | -102.44 M | -115.58 M | -177.72 M | -291.9 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 3.54% | 3.42% | — | — |
| Earnings Growth % | -5.32% | 23.09% | — | — |
| Profit Margin % | 10.54% | 11.52% | 9.68% | — |
| Operating Margin % | 16.8% | 17% | 17.51% | — |
| Gross Margin % | 70% | 70.08% | 70.52% | — |
| EBITDA Margin % | 20.42% | 20.69% | 20.88% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.